Slow Capital, Inc. Nektar Therapeutics Transaction History

Slow Capital, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$16.56 - $25.46 $221,390 - $340,374	-13,369 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$15.77 - $19.03 $1,782 - $2,150	-113 Reduced 0.84%	13,369 $227,000
Q3 2020 Nov 04, 2020	SELL	$16.59 - $24.79 $92,489 - $138,204	-5,575 Reduced 29.25%	13,482 $224,000
Q2 2020 Aug 10, 2020	BUY	$16.86 - $23.44 $7,165 - $9,962	425 Added 2.28%	19,057 $441,000
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $30,980 - $59,862	2,141 Added 12.98%	18,632 $333,000
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $261,712 - $381,271	16,491 New	16,491 $356,000
Q3 2019 Nov 07, 2019	SELL	$16.91 - $36.27 $187,278 - $401,690	-11,075 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$31.0 - $36.3 $162,564 - $190,357	-5,244 Reduced 32.13%	11,075 $394,000
Q1 2019 May 16, 2019	SELL	$31.58 - $46.35 $4,326 - $6,349	-137 Reduced 0.83%	16,319 $548,000
Q4 2018 Jan 30, 2019	BUY	$30.43 - $56.65 $136,235 - $253,622	4,477 Added 37.37%	16,456 $541,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $21,743 - $32,053	468 Added 4.07%	11,979 $730,000
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $190,827 - $430,960	-4,126 Reduced 26.39%	11,511 $562,000
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $14,694 - $27,760	256 Added 1.66%	15,637 $1.66 Million
Q4 2017 Feb 15, 2018	BUY	$23.02 - $60.5 $354,070 - $930,550	15,381	15,381 $919,000

168

123M

1.18M

64.6K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $1.79B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.